Cybernet Data Systems Inc.
BioMarin Pharmaceutical Inc. Sells Rare Pediatric Disease Priority Review Voucher for $110M
BioMarin Pharmaceutical Inc. announced the sale of its Rare Pediatric Disease Priority Review Voucher (PRV) to an undisclosed purchaser for a lump sum payment of $110,000,000. The company received the voucher under a Food and Drug Administration (FDA) program intended to encourage the development of treatments for rare